Your browser doesn't support javascript.
loading
Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.
Oksvold, Morten P; Berglund, Ulrika Warpman; Gad, Helge; Bai, Baoyan; Stokke, Trond; Rein, Idun Dale; Pham, Therese; Sanjiv, Kumar; Øy, Geir Frode; Norum, Jens Henrik; Smeland, Erlend B; Myklebust, June H; Helleday, Thomas; Våtsveen, Thea Kristin.
Afiliación
  • Oksvold MP; Department of Cancer Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Ullernschausseen 70, 0379, Montebello, Oslo, Norway.
  • Berglund UW; KG Jebsen Centre for B Cell Malignancies, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Gad H; Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
  • Bai B; Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
  • Stokke T; Weston Park Cancer Centre, Department of Oncology and Metabolism, University of Sheffield, Sheffield, S10 2RX, UK.
  • Rein ID; Department of Cancer Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Ullernschausseen 70, 0379, Montebello, Oslo, Norway.
  • Pham T; KG Jebsen Centre for B Cell Malignancies, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Sanjiv K; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Øy GF; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Norum JH; Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
  • Smeland EB; Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
  • Myklebust JH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Helleday T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Våtsveen TK; Department of Cancer Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Ullernschausseen 70, 0379, Montebello, Oslo, Norway.
Sci Rep ; 11(1): 6317, 2021 03 18.
Article en En | MEDLINE | ID: mdl-33737576
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Linfoma de Células B / Linfoma de Burkitt / Monoéster Fosfórico Hidrolasas / Enzimas Reparadoras del ADN Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Linfoma de Células B / Linfoma de Burkitt / Monoéster Fosfórico Hidrolasas / Enzimas Reparadoras del ADN Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido